-
SB 202190: p38 MAP Kinase Inhibitor Workflows
2026-09-02
SB 202190 enables controlled inhibition of p38α/β signaling in inflammation research, cancer therapeutics research, and regulated cell-death assays. This guide connects practical dosing and controls with RIPK1-focused experimental design, helping researchers distinguish p38 pathway effects from apoptosis or necroptosis mechanisms.
-
Bardoxolone methyl: Redox Assay Workflows
2026-09-02
Build more interpretable oxidative stress and cancer assays with Bardoxolone methyl, also known as CDDO methyl ester. This guide connects KEAP1–Nrf2 activation and NF-kB inhibition with thioredoxin–RNR–CHK1 biology while providing practical dosing, controls, and troubleshooting strategies.
-
Dabigatran Acylglucuronide Has Weaker Anticoagulant Activity
2026-09-01
The 2022 Pharmaceutics study directly compared dabigatran with its major active metabolite, dabigatran acylglucuronide, across thrombin-generation and routine coagulation assays. Although both compounds inhibited coagulation in a concentration-dependent manner, the metabolite required higher concentrations to produce comparable effects, an observation that informs interpretation of dabigatran exposure and assay data.
-
4-Ethylphenyl Sulfate: From Signal to Clearance
2026-09-01
4-Ethylphenyl sulfate is a microbiota-linked metabolite relevant to autism-spectrum and renal research. This article presents a clearance-aware framework that connects biomarker interpretation, behavioral studies, mass spectrometry, and cyclodextrin-based adsorption experiments.
-
Perospirone: An Assay-First Pharmacology Guide
2026-08-31
Perospirone (SM-9018 free base) combines high-affinity serotonergic and dopaminergic receptor activity with a newly characterized vascular Kv-channel effect. This assay-first guide explains how to separate receptor pharmacology from off-target ion-channel responses in schizophrenia research and neurovascular models.
-
Probenecid: An Assay-First Mechanistic Guide
2026-08-30
Probenecid, also known as 4-(dipropylsulfamoyl)benzoic acid, is best interpreted through an assay-first framework that separates transporter, pannexin-1, and neuroinflammatory effects. This guide connects those decisions to CD8+ T-cell metabolic flexibility while clearly defining the limits of current evidence.
-
Dual-Readout mRNA for Translational Delivery
2026-08-29
A mechanistic framework for using dual fluorescence and bioluminescence reporters to separate mRNA delivery, intracellular trafficking, and productive translation in advanced therapeutic platforms.
-
AhR–RBX1–HSF1 Signaling in Acute Pancreatitis
2026-08-29
Fang and colleagues identify an aryl hydrocarbon receptor–RBX1–HSF1 regulatory axis that links pancreatic acinar-cell stress responses with tight-junction preservation and macrophage polarization during acute pancreatitis. The study combines a severe cerulein/LPS model, primary acinar-cell experiments, database-guided interaction analysis, and pharmacological interference to provide a mechanistic framework for barrier protection.
-
AM 281: CB1 Cannabinoid Receptor Antagonist Workflows
2026-08-28
AM 281 combines nanomolar CB1 affinity with a large CB2 selectivity gap, supporting receptor-binding, astrocyte–neuron mechanism, and traumatic brain injury assays. This practical workflow shows how to control solubility, bracket concentrations, and connect GLT-1, CREB, apoptosis, and cognition without overinterpreting an inverse agonist.
-
Scalable EPSC-Derived MSC EVs: Study Analysis
2026-08-28
Gong et al. developed a bioreactor-based platform that generates extracellular vesicles from EPSC-derived mesenchymal stromal cells at substantially greater scale and with more standardized production than conventional primary MSC systems. In a bleomycin-induced pulmonary fibrosis model, these iMSC-EVs showed structural, molecular, and therapeutic characteristics comparable to primary MSC-EVs, supporting their potential for translational manufacturing.
-
Estradiol Benzoate Assay Workflow Guide
2026-08-27
Build reproducible estrogen receptor alpha agonist experiments with practical stock-preparation, dosing, binding, reporter, and troubleshooting guidance. Estradiol Benzoate supports both quantitative receptor interaction studies and cell-based estrogen receptor signaling research when vehicle, timing, and orthogonal controls are managed carefully.
-
Ceapin-A7 in Bone ER Stress Research
2026-08-27
Use Ceapin-A7 as a pathway-resolving probe to test whether ATF6α contributes to glucocorticoid-associated bone-cell stress, apoptosis, or impaired osteogenesis. This workflow complements the PTX3–TLR4/NF-κB/FGF21 model while keeping ATF6α inhibition experimentally distinct from broad ER-stress suppression.
-
CCK8s, NOX4, and ANP Secretion in Rat Atria
2026-08-26
This study identifies a mechanistic pathway through which sulfated cholecystokinin octapeptide stimulates ANP secretion in isolated beating rat atria. Its experiments connect CCK receptor signaling to cPLA2-derived arachidonic acid, NOX4-generated H2O2, PGC-1α, and PPARα/PPARγ, while also indicating that ANP feeds back on oxidative-stress regulation.
-
Gramine Targets CUL3–MTDH to Trigger TNBC Ferroptosis
2026-08-26
The reference study identifies Gramine as a selective inhibitor of triple-negative breast cancer models and links its activity to a previously underexplored CUL3–MTDH ubiquitination axis. By combining target-engagement assays, ferroptosis rescue experiments, genetic perturbation, and xenograft studies, the work provides a mechanistic framework for studying ferroptosis in TNBC.
-
Microplastics, Nanoplastics, and Pulmonary Fibrosis
2026-08-25
A 2026 Toxicology study compared polystyrene, polyethylene, and polypropylene particles across micro- and nanoscale size classes in mouse and BEAS-2B lung models. The results identify stronger toxicity for polystyrene nanoplastics and implicate dysregulation of the FXR–YAP1 axis in fibrotic and inflammatory responses.
451 records 6/31 page Previous Next First page 上5页 678910 下5页 Last page